Literature DB >> 11733187

Cloning and characterization of a novel human transcription factor AP-2 beta like gene (TFAP2BL1).

Chao Cheng1, Kang Ying, Ming Xu, Wei Zhao, Zongxiang Zhou, Yan Huang, Wei Wang, Jian Xu, Li Zeng, Yi Xie, Yumin Mao.   

Abstract

The AP-2 transcription factor has been shown to play an important role in development, morphogenesis, apoptosis, cell-cycle control and has also been implicated in mammary oncogenesis. Here we report the cloning and characterization of a novel human transcription factor AP-2 like gene (TFAP2BL1), which is located on human chromosome 6p12.1-21.1. The TFAP2BL1 cDNA is 2076 base pairs in length, encoding a 452-amino acid polypeptide related to human Ap-2protein. TFAP2BL1 gene has significantly high homology to transcription factor AP-2 gene of human, mouse, chicken, sheep, fruit fly, and C. elegans at amino acid level. RT-PCR analysis shows its relatively high expression level in adult thymus, prostate, small intestine, skeletal muscle, placenta, brain, and testis tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11733187     DOI: 10.1016/s1357-2725(01)00098-x

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

1.  Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Authors:  Jessica Finlay-Schultz; Andrew Canastar; Margaret Short; Mohamed El Gazzar; Christina Coughlan; Sherry Leonard
Journal:  J Biol Chem       Date:  2011-10-06       Impact factor: 5.157

2.  Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression.

Authors:  Douglas Vernimmen; Dominique Begon; Christophe Salvador; Stéphanie Gofflot; Madeleine Grooteclaes; Rosita Winkler
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  AP2 transcription factor induces apoptosis in retinoblastoma cells.

Authors:  Xiaodong Li; Darryl D Glubrecht; Roseline Godbout
Journal:  Genes Chromosomes Cancer       Date:  2010-09       Impact factor: 5.006

4.  Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes.

Authors:  Francesca Orso; Davide Corà; Benedetta Ubezio; Paolo Provero; Michele Caselle; Daniela Taverna
Journal:  BMC Genomics       Date:  2010-06-03       Impact factor: 3.969

5.  Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.

Authors:  Francesca Orso; Erika Cottone; Mark D Hasleton; J Claire Ibbitt; Piero Sismondi; Helen C Hurst; Michele De Bortoli
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

Review 6.  The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential.

Authors:  Mohamed H Al-Sabri; Maryam Nikpour; Laura E Clemensson; Misty M Attwood; Michael J Williams; Mathias Rask-Anderson; Jessica Mwinyi; Helgi B Schiöth
Journal:  Cell Biosci       Date:  2022-09-08       Impact factor: 9.584

7.  The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors.

Authors:  Abdelkader Allouche; Gregory Nolens; Annalisa Tancredi; Laurence Delacroix; Julie Mardaga; Viviana Fridman; Rosita Winkler; Jacques Boniver; Philippe Delvenne; Dominique Y Begon
Journal:  Breast Cancer Res       Date:  2008-01-24       Impact factor: 6.466

8.  Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion.

Authors:  Christoph Fraune; Luisa Harms; Franziska Büscheck; Doris Höflmayer; Maria Christina Tsourlakis; Till S Clauditz; Ronald Simon; Katharina Möller; Andreas M Luebke; Christina Möller-Koop; Stefan Steurer; Claudia Hube-Magg; Guido Sauter; Sören Weidemann; Patrick Lebok; David Dum; Simon Kind; Sarah Minner; Jakob R Izbicki; Thorsten Schlomm; Hartwig Huland; Hans Heinzer; Eike Burandt; Alexander Haese; Markus Graefen; Cornelia Schroeder
Journal:  Mol Med       Date:  2020-03-06       Impact factor: 6.354

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.